Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis

Area of Science:

• Genomics
• Molecular Biology
• Cancer Research

Background:

• The OKL38 gene's growth inhibitory properties and role in mammary carcinogenesis were previously established.
• Further understanding of OKL38 regulation and its involvement in tumorigenesis is crucial.

Purpose of the Study:

• To clone and characterize the human OKL38 gene and its variants.
• To investigate the expression patterns and functional roles of OKL38 in kidney tumorigenesis.

Main Methods:

• Gene cloning and characterization, including analysis of exons, introns, and transcript variants.
• Reverse transcription-polymerase chain reaction (RT-PCR) and sequence analysis for transcript diversity.
• Expression analysis using Multiple Tissue Expression array (MTE), Multiple Tissue Northern blot (MTN), and Cancer Profiling Array (CPA).
• Western blot and immunohistological analysis to assess protein levels in tumor tissues.
• Cell transfection studies to evaluate the functional impact of OKL38 overexpression.

Main Results:

• The human OKL38 gene spans approximately 18 kb with 8 exons and 7 introns, generating transcripts of 1.9, 2.2, and 2.4 kb via differential promoter usage and alternative splicing.
• OKL38 is ubiquitously expressed, with high levels in liver, kidney, and testis.
• OKL38 mRNA was down-regulated in 70% of kidney tumors, and the protein was undetectable or underexpressed in 78% of tumor tissues.
• Overexpression of OKL38 in kidney cancer cells (A498) resulted in significant growth inhibition and cell death.

Conclusions:

• The OKL38 gene exhibits a complex genomic structure and alternative splicing.
• OKL38 possesses growth inhibitory and cytotoxic properties, particularly relevant to kidney cancer.
• Down-regulation of OKL38 in kidney tumors suggests its potential as a biomarker for diagnosis, prognosis, and therapeutic target.